Evidence map›Paper›PMID 32019329›Full record

ArticleJournal of diabetes science and technology2020

Exposure to Closed Loop Barriers Using Virtual Reality.

Monica Lanning, Jessica Shen, Daniel Wasser, Scott Riddle, Bianca Agustin, Korey Hood, Diana Naranjo

Open access · bronzeAbstract read
In one paragraph

Article in Journal of diabetes science and technology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Monica LanningDepartment of Pediatrics, Stanford University School of Medicine, CA, USA.ORCID 0000-0001-5178-8238
Jessica ShenBoston University School of Medicine, MA, USA.
Daniel WasserPhoton Biomedical, Philadelphia, PA, USA.
Scott RiddlePhoton Biomedical, Philadelphia, PA, USA.
Bianca AgustinKaiser Permanente, Oakland, CA, USA.
Korey HoodDepartment of Pediatrics, Stanford University School of Medicine, CA, USA.ORCID 0000-0001-5730-7749
Diana NaranjoDepartment of Pediatrics, Stanford University School of Medicine, CA, USA.ORCID 0000-0001-8039-0616
Stanford University · USBoston University · USKaiser Permanente · US

Funding

Stanford Islet Research CoreP30DK116074 · NIDDK · STANFORD UNIVERSITY · PI Seung K Kim · 2017 to 2026
$19.5M
NIDDK NIH HHS P30 DK116074
6 · The paper itself

Abstract

backgroundClosed loop (CL) automated insulin delivery systems are demonstrated to be safe and effective in regulating glucose levels and reducing cognitive burden in people with type 1 diabetes (T1D). However, given the limited market options and the do-it-yourself nature of most systems, it can be difficult for potential users to shape their expectations fitting them into daily lives and management routines. As such, we examined the potential feasibility of a virtual reality (VR) intervention.

methodsA four-part VR intervention was created to expose adults with T1D to expected CL system barriers: body image, perceived hassles of using CL, deskilling fears, and unwanted social attention. Goals of the pilot were to assess feasibility and expose patients to CL. Surveys were conducted pre- and postparticipating in the VR experience.

resultsA total of 20 adults with T1D completed the pilot. Average time to complete the experience was 14.1 minutes (8.8-39.9). Reported VR sickness was low. Willingness to use VR was maintained in 90% (

conclusionThis pilot VR intervention demonstrated high potential in addressing expected barriers to uptake and usage of CL systems without decreasing enthusiasm or changing expectations of CL.

Indexed as

Glycemic ControlInsulin Infusion SystemsVirtual RealityAdolescentAdultAttitude to ComputersBiomarkersBlood GlucoseDiabetes Mellitus, Type 1Feasibility StudiesFemaleHealth Knowledge, Attitudes, PracticeHumansHypoglycemic AgentsInsulinMaleBiomarkersBlood GlucoseHypoglycemic AgentsInsulinclosed loop insulin delivery systemtechnologytype 1 diabetesvirtual reality

Identifiers

PMID32019329
PMCPMC7753868
OpenAlexW3004615696

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.